Medistim
MEDI.OL
#7773
Rank
โ‚น19.04 B
Marketcap
โ‚น1,040
Share price
-2.52%
Change (1 day)
N/A
Change (1 year)

P/E ratio for Medistim (MEDI.OL)

P/E ratio as of November 2024 (TTM): 22.5

According to Medistim's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.4654. At the end of 2023 the company had a P/E ratio of 37.7.

P/E ratio history for Medistim from 2010 to 2024

PE ratio at the end of each year

Year P/E ratio Change
202337.71.94%
202237.0-49.81%
202173.612.24%
202065.632.26%
201949.6133.21%
201821.3-22.59%
201727.5-19.61%
201634.241.83%
201524.151.63%
201415.91.6%
201315.629.86%
201212.0-48.8%
201123.5-4%
201024.564.49%
200914.9-31.37%
200821.781.12%
200712.0-31.81%
200617.6-12.11%
200520.03.3%
200419.4

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.